Dawn Adams, MD
Gastroenterology · Nashville, TNNPI 1588807168
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,958 of the $19,714 with a category attached, or 91.1%. 5 manufacturers reported payments, led by Ironwood Pharmaceuticals, Inc at 50.2% of the total. Reporting peaked in 2024 at $16,708 and has fallen 94.7% since, to $882 in 2025. Among gastroenterology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 15 payments — averaging $1314.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironwood Pharmaceuticals, Inc$10K
- Takeda Pharmaceuticals U.S.A., Inc.$9K
- Chugai Pharmaceutical Co., Ltd.$830
- Zealand Pharma A/s$353
- Taiho Oncology, Inc.$12
Across 460 payments — averaging $1427.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$464K
- Zealand Pharma A/s$112K
- Vectivbio AG$49K
- Cormedix Inc.$32K
What the payments were for
- Consulting fees$17,95891%
- Travel & lodging$1,4007%
- Food & beverage$3572%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironwood Pharmaceuticals, Inc | 7 | $9,893 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $8,626 |
| Chugai Pharmaceutical Co., Ltd. | 1 | $830 |
| Zealand Pharma A/s | 2 | $353 |
| Taiho Oncology, Inc. | 1 | $12 |
How this compares
$19,714 in reported general payments places this provider in the 90th percentile of 336 gastroenterology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GattexTeduglutide | 47 | $2,746,408 |
| Sodium Chloride0.9 % Sodium Chloride | 258 | $9,089 |
| Magnesium Sulfate | 105 | $7,781 |
| Sodium Acetate | 66 | $2,903 |
| Sodium ChlorideSodium Chloride 0.45 % | 33 | $2,225 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 73 | $991 |
| Gentamicin Sulfate | 128 | $820 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 25 | $403 |
| Lactated RingersRinger's Solution,lactated | 24 | $313 |
| Omeprazole | 17 | $280 |
| FamotidineFamotidine/Pf | 21 | $274 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gattex | $8,626 | $2,746,40847 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 336 gastroenterology providers in Tennessee.
Other gastroenterology in Nashville
- David SchwartzNashville$1.3M
- Dawn Borromeo BeaulieuNashville$421K
- Sara HorstNashville$246K
- Rishi NaikNashville$136K
- Dhyanesh PatelNashville$98K
- Michael VaeziNashville$78K
- Baldeep PablaNashville$55K
- Robin DalalNashville$27K
- Howard MertzNashville$26K
- Matthew NeffNashville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.